2227548-95-8
Chemical Structure
SLC13A5-IN-1
- CAS No.: 2227548-95-8
- Formula:C19H19Cl3N2O3S
- Molecular Weight:461.79
IUPAC Name: N-(4-chlorobenzyl)-1-((3,5-dichlorophenyl)sulfonyl)piperidine-4-carboxamide
InChIKey: NPEIWANTVUZMJV-UHFFFAOYSA-N
SMILES: O=C(C1CCN(S(=O)(C2=CC(Cl)=CC(Cl)=C2)=O)CC1)NCC3=CC=C(Cl)C=C3
Biological Activity: SLC13A5-IN-1 is a selective sodium-citrate co-transporter (SLC13A5) inhibitor. SLC13A5-IN-1 completely blocks the uptake of 14C-citrate with an IC50 value of 0.022 μM in HepG2 cells. SLC13A5-IN-1 has the potential for the treatment of metabolic and/or cardiovascular diseases. SLC13A5-IN-1 is extracted from patent WO2018104220A1, Compound I-5[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SLC13A5-IN-1 | 98.62% | SLC13A5-IN-1 is a selective sodium-citrate co-transporter (SLC13A5) inhibitor. SLC13A5-IN-1 completely blocks the uptake of 14C-citrate with an IC50 value of 0.022 μM in HepG2 cells. SLC13A5-IN-1 has the potential for the treatment of metabolic and/or cardiovascular diseases. SLC13A5-IN-1 is extracted from patent WO2018104220A1, Compound I-5. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
